Publications
Publications
Show Results For
- All HBS Web
(120,207)
- Faculty Publications (139)
- April 2003 (Revised February 2004)
- Case
Kodak (A)
By: Giovanni M. Gavetti, Rebecca Henderson and Simona Giorgi
The introduction of digital imaging in the late 1980s had a disruptive effect on Kodak's traditional business model. Examines Kodak's strategic efforts and challenges as the photography industry evolves. After discussing Kodak's history and its past strategic moves in... View Details
- February 2003 (Revised July 2003)
- Case
Ember Corporation: Developing the Next Ubiquitous Network Standard
By: Rebecca Henderson and Nancy Confrey
Ember is a venture capital-funded start-up that hopes to establish a standard for ubiquitous wireless networks. Its unique approach and proprietary technology promises to create enormous value in a wide variety of markets, particularly in local sensing and control.... View Details
- Article
Discontinuities and Senior Management: Assessing the Role of Recognition in Pharmaceutical Firm Response to Biotechnology
By: Rebecca M. Henderson, Sarah Kaplan and Fiona Murray
- November 2002 (Revised June 2003)
- Case
Corning, Inc.: Technology Strategy in 2003
Corning, Inc. has a 150-year history of building a strategy around innovation. Founded as a glass manufacturer in 1851, the company quickly established itself as a maker of specialty glass products and over the next 100 years diversified into light bulbs, television,... View Details
- January 2002
- Article
Putting Patents in Context: Exploring Knowledge Transfer from MIT
By: Ajay Agrawal and Rebecca M. Henderson
- 2001
- Chapter
Publicly Funded Science and the Productivity of the Pharmaceutical Industry
By: Rebecca Henderson and Ian Cockburn
U.S. taxpayers funded $14.8 billion of health related research last year, four times the amount that was spent in 1970 in real terms. In this paper we evaluate the impact of these huge expenditures on the technological performance of the pharmaceutical industry. While... View Details
- Article
Scale and Scope in Drug Development: Unpacking the Advantages of Size in Pharmaceutical Research
By: Rebecca Henderson and Iain Cockburn
- 2000
- Chapter
'Luck', 'Leadership' and 'Strategy'
- 2000
- Chapter
Measuring Competence? Exploring Firm Effects in Drug Discovery
By: Rebecca M. Henderson and Iain Cockburn
- fall 2000
- Article
Putting Patents in Context: Exploring Knowledge Transfer from MIT
By: Rebecca M. Henderson and Ajay Agrawal
- Article
Untangling the Origins of Competitive Advantage
By: Rebecca M. Henderson, Iain Cockburn and Scott Stern
- July – August 2000
- Article
Drug Industry Mergers Won't Necessarily Benefit R&D
- 1999
- Chapter
The Pharmaceutical Industry and the Revolution in Molecular Biology: Interactions Among Scientific, Institutional, and Organizational Change
By: Rebecca Henderson, Gary P. Pisano and Luigi Orsenigo
- Article
Absorptive Capacity, Coauthoring Behavior, and the Organization of Research in Drug Discovery
By: Rebecca M. Henderson and Iain Cockburn
- Article
The Perils of Excellence: Barriers to Effective Process Improvement in Product-Driven Firms
By: Rebecca M. Henderson, Jesus del Alamo, Todd Becker, James Lawton, Peter Moran, Saul Shapiro and Dean Vlasak
- Article
The Interactions of Organizational and Competitive Influences on Strategy and Performance
By: Rebecca M. Henderson and Will Mitchell
- 1997
- Article
University versus Corporate Patents: A Window on the Basicness of Invention
By: Rebecca M. Henderson, Adam Jaffe and Manuel Trajtenberg